Moderna Inc (MRNA) USD0.0001

Sell:$41.04Buy:$41.06$0.29 (0.71%)

NASDAQ:0.25%
Market closed | Prices delayed by at least 15 minutes
Sell:$41.04
Buy:$41.06
Change:$0.29 (0.71%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:$41.04
Buy:$41.06
Change:$0.29 (0.71%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.

Key people

Stephen Hoge
President
Stephane Bancel
Chief Executive Officer, Director
James M. Mock
Chief Financial Officer
Jerh Collins
Chief Technical Operations and Quality Officer
Tracey Franklin
Chief People and Digital Technology Officer
Brad Miller
Chief Information Officer
Kate Cronin
Chief Brand Officer
Jacqueline Miller
Chief Medical Officer
Shannon Thyme Klinger
Corporate Secretary, Chief Legal Officer
Noubar B. Afeyan
Non-Executive Independent Chairman of the Board, Co-Founder
Abbas Hussain
Director
David M. Rubenstein
Director
Sandra J. Horning
Independent Director
Elizabeth G. Nabel
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US60770K1079
  • Market cap
    $17.29bn
  • Employees
    5,600
  • Shares in issue
    384.82m
  • Exchange
    NASDAQ
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.